News BenevolentAI names pharma vet Jörg Möller as its new CEO BenevolentAI’s search for a new chief executive has concluded with the appointment of industry bigwig Dr Jörg Möller to the role, four months after Joanna Shields stepped
Views & Analysis LEO Pharma’s new R&D lead on driving agility in drug develop... After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development.
News UK Biobank charts success of NHS imaging project The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face